Showing results (371-380 of 385) with videos related to

Sort By:
Pageof 39
NPJ Digital Medicine|December 21, 2021
Smartphone-based digital phenotyping for dry eye toward P4 medicine: a crowdsourced cross-sectional studyTakenori Inomata, Masahiro Nakamura, Jaemyoung Sung, et al.
The Ocular Surface|May 25, 2025
Safety of subconjunctival injection of mesenchymal stromal cells in persistent corneal epithelial disease - A phase 1b clinical trialGrace C Tu, Farshad Abedi, Arthur Y Chang, et al.
Japanese Journal of Ophthalmology|January 7, 2021
Heterogeneity of eye drop use among symptomatic dry eye individuals in Japan: large-scale crowdsourced research using DryEyeRhythm applicationAtsuko Eguchi, Takenori Inomata, Masahiro Nakamura, et al.
Nature Communications|March 4, 2025
Cultivated autologous limbal epithelial cell (CALEC) transplantation for limbal tem cell deficiency: a phase I/II clinical trial of the first xenobiotic-free, serum-free, antibiotic-free manufacturing protocol developed in the USUla V Jurkunas, Aaron R Kaufman, Jia Yin, et al.
Investigative Ophthalmology & Visual Science|October 16, 2014
Consensus statement on the immunohistochemical detection of ocular lymphatic vesselsFalk Schroedl, Alexandra Kaser-Eichberger, Simona L Schlereth, et al.
The Ocular Surface|July 25, 2017
TFOS DEWS II Management and Therapy ReportLyndon Jones, Laura E Downie, Donald Korb, et al.
Eye (London, England)|April 15, 2023
Symptom-based stratification algorithm for heterogeneous symptoms of dry eye disease: a feasibility studyKen Nagino, Takenori Inomata, Masahiro Nakamura, et al.
Translational Vision Science & Technology|August 12, 2021
Preclinical Evaluation of the Safety and Efficacy of Cryopreserved Bone Marrow Mesenchymal Stromal Cells for Corneal RepairIlham Putra, Xiang Shen, Khandaker N Anwar, et al.
Science Advances|August 18, 2023
Cultivated autologous limbal epithelial cell (CALEC) transplantation: Development of manufacturing process and clinical evaluation of feasibility and safetyUla V Jurkunas, Jia Yin, Lynette K Johns, et al.
Blood Cancer Journal|May 27, 2021
Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM)Sagar Lonial, Ajay K Nooka, Praneetha Thulasi, et al.
Pageof 39